|
|
|
|
|
by rch
2050 days ago
|
|
There's also a strategic capabilities argument that never goes away. I'm anticipating a significant investment in synthetic biology facilities in the next few years. Ideally these would be 99% automated, remotely operated via secure dedicated networks, and maintained by small on-site skeleton crews. They'd be geographically distributed, with a majority in 'red states', but not because of any jobs they might create. |
|